← Back to Search

Behavioral Intervention

Expressive Helping for Mental Health Issue

N/A
Waitlist Available
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 1-month follow-up and 3-month follow-up
Awards & highlights

Study Summary

This study is evaluating whether a writing intervention can help caregivers of cancer patients.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 1-month follow-up and 3-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 1-month follow-up and 3-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in caregiver quality of life assessed by the Caregiver quality of life index - Cancer
Changes in depressive symptoms assessed by the Center for Epidemiologic Studies Depression Scale
Changes in life satisfaction assessed by the Satisfaction with Life Scale.
Secondary outcome measures
Changes in caregiver strain assessed by the Zarit Burden Interview
Changes in intrusive thoughts assessed by the Impact of Event scale.
Changes in post-traumatic growth assessed by the Post-traumatic Growth Inventory
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Expressive Helping writingExperimental Treatment1 Intervention
During the first writing session, participants will be informed that people benefit from learning about other cancer caregivers' experiences, and that the first three sessions will consist of writing exercises designed to help them think about their cancer caregiving experiences and to prepare them for writing a helpful letter to other Chinese cancer caregivers during the fourth and final writing session.
Group II: Caregiving Facts writingActive Control1 Intervention
During each week, participants in the control group will be asked to write facts about their experience with cancer caregiving (e.g., type of treatment their loved one is receiving) and will be asked to avoid writing about their emotions. Participants in this group will be told that their writing will not be shared with others outside of the research team.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Expressive Helping
2022
Completed Phase 3
~710

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor
226 Previous Clinical Trials
314,188 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~15 spots leftby Apr 2025